Ronald J. Doll
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Protein Kinase Regulation and GTPase Signaling, Click Chemistry and Applications, Microtubule and mitosis dynamics, Advanced Breast Cancer Therapies
Most-Cited Works
- → A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer(1957)560 cited
- → Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor(2010)557 cited
- Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.(1998)
- → Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases(2010)175 cited
- → Novel Tricyclic Inhibitors of Farnesyl Protein Transferase(1995)155 cited
- → Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d).(1994)136 cited
- → Selective halogenation of steroids using attached aryl iodide templates